Alvotech Completes Key FDA Inspection to Keep US Expansion Plans on Schedule

Reykjavik, Monday, 11 May 2026.
Following a critical FDA inspection in Iceland, Alvotech remains on track for its second-quarter US product submissions, prioritizing long-term market growth despite a recent 20% quarterly revenue dip.